^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Breast Cancer
    Drug:anastrozole (Aromatase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    12/13/2018
    Excerpt:
    ARIMIDEX is an aromatase inhibitor indicated for:...First-line treatment of postmenopausal women with hormone receptorpositive or hormone receptor unknown locally advanced or metastatic breast cancer.